Purpose: To investigate the vitreopapillary interface (VPI) in health and glaucoma according to the different stages of posterior vitreous detachment (PVD) formation. Methods: Prospective single centre study including healthy subjects and glaucoma patients. PVD staging was performed with spectral domain optical coherence tomography. Gender, age, lens status and refractive error were assessed in both groups. Glaucoma patients additionally had a comprehensive ophthalmological investigation including intraocular pressure measurement, visual field testing and confocal imaging of the optic nerve head. Results: Data on 523 subjects (993 eyes) were included from the VPI study (clinicaltrials.gov NCT02290795) database (493 eyes of 258 healthy subjects and 500 eyes of 265 glaucoma patients). Healthy subjects were significantly younger than primary open angle glaucoma patients (59.7 AE 14.81 versus 70.0 AE 10.78 years, p < 0.001), but were otherwise matched for refractive error and gender. Significantly more glaucomatous eyes were pseudophakic (26.6% versus 5.1%). Including only phakic nonoperated eyes from subjects between 50 and 80 years old decreased the age difference between healthy and open angle glaucoma (64.1 AE 8.0 versus 65.9 AE 6.7 years, p = 0.051). Comparing these subgroups rendered similar average ages for PVD stages 0 and 4, in contrast to the significant older age for the glaucoma subgroup in stage 1 (64.1 AE 6.01 versus 61.4 AE 8.38 years, p < 0.001) and a trend towards significance in stage 3 (70.8 AE 69.8 versus 67.5 AE 5.92 years, p = 0.051).
Introduction
The vitreous is a gel-like structure filling the posterior chamber of the eye (Sebag 2014) . It is mainly composed of water but retains its shape through a dense meshwork of collagen fibres that anchor it to the retina (Bishop 1996) . Strong vitreoretinal attachments are present at the vitreous base and the posterior pole, especially over the macular region and the optic disc (Sebag 1992 (Sebag , 2014 . With ageing, the natural vitreous liquefies (syneresis) and centrally collapses (synchysis) resulting in a separation of the posterior vitreous cortex from the retina (Le Goff & Bishop 2008; Ponsioen et al. 2010 ). This is a stepwise process possibly taking several decades and is otherwise known as posterior vitreous detachment (PVD) (Sebag 1997; Johnson 2005) . Epidemiological data in healthy subjects indicate a variable time of onset and progression to complete PVD in healthy subjects (Uchino et al. 2001; Johnson 2010; Itakura & Kishi 2013; Itakura et al. 2014) . The majority of the general population experiences PVD formation during their lifetime. Normally, this is an uneventful evolution, but in some cases, the vitreous cortex remains firmly attached at the posterior pole and can exert significant traction, resulting in vitreomacular traction (VMT) and vitreopapillary traction (VPT) with subsequent changes in retinal architecture (Stalmans et al. 2013) . Vitreomacular traction (VMT) has been studied extensively resulting in a separate classification and several pharmacologic and surgical treatment options (Duker et al. 2013) .
Vitreopapillary traction (VPT), on the other hand, has not been the subject of investigation to that extent, although this could also have a profound effect on visual acuity and visual field (Katz & Hoyt 2005; Meyer et al. 2007; Houle & Miller 2012) . This is illustrated by numerous publications investigating the relationship between vitreopapillary adhesion (VPA) and macular hole, diabetic retinal oedema, macular oedema associated with premacular membrane (PMM) and retinal vein occlusion (Chauhan et al. 2000; Rumelt et al. 2003; Karatas et al. 2005; Sebag et al. 2009; Wang et al. 2009; Krebs et al. 2011; Romano et al. 2015; Sebag 2015) . Furthermore, there are case reports suggesting that VPT could cause optic nerve head elevation and haemorrhages, and even visual field defects (Katz & Hoyt 1995; Wisotsky et al. 1998; Kokame et al. 2004; Sibony et al. 2008; Nomura et al. 2010; Wong et al. 2012; Hwang & Lin 2014) . Indeed, Kim et al. (2014) reported significantly lower mean deviations (MD) on automated perimetry in PMM patients with VPT compared to those without. Furthermore, there are reports of VPA being responsible for changes in retinal nerve fibre layer (RNFL) thickness and even retinal serous detachment (Aras et al. 2008; Hwang & Kim 2015) . These marked changes in optic disc morphology could have a profound influence on an optical coherence tomography (OCT) or confocal laser scanning tomography based glaucoma assessment and have been hinted as a major source of artefacts in automated readings of RNFL (Batta et al. 2010) . Currently, these technologies are being extensively used to provide information about the shape and cupping of the optic disc and RNFL and take into assumption the optic disc landmark to remain stable through time.
The purpose of the vitreopapillary interface (VPI) study (NCT02290795) is to build a large database of healthy and glaucomatous eyes with and without VPA and VPT to investigate the role of the vitreous in glaucoma. This manuscript details the methods used and focuses on the age-related process of PVD formation in both healthy and primary open angle glaucoma (POAG) patients.
Materials and Methods

Healthy subjects recruitment
Inclusion was offered to all visitors of the free eye screening organized during the World Sight Day on 2 November 2015 in the University Hospitals Leuven, as well as to individuals' accompanying glaucoma patients and to patients prior to cataract surgery in the University Hospitals Leuven ophthalmology department. All subjects willing to sign informed consent were asked for their medical history, gender, age and refractive error, and underwent an OCT scan (Cirrus 4000; Carl Zeiss, Dublin, CA, USA) of the macula and optic disc. Biomicroscopy and fundoscopy completed the ophthalmological examination. All OCT data and subject files were screened by a glaucoma specialist (IS) and those with a family history of glaucoma, an enlarged cup/disc ratio or any other optic disc abnormality (optic nerve head haemorrhage, notching) leading to the suspicion of glaucomatous damage were excluded from further analysis, in accordance to the methodology used in the Leuven Eye Study (Abegão Pinto et al. 2016) . If the OCT scan revealed any sort of disease or if there were specific symptoms, patients were referred to the ophthalmology consultation for a comprehensive work-up. Only those without any form of ocular disease or previous intraocular surgery except for uneventful cataract surgery were included for analysis. Only OCT scans with an average quality rating of 6 or more (out of 10) were included for analysis.
Glaucoma patients recruitment
Two groups of glaucoma patients were recruited prospectively in the University Hospitals Leuven glaucoma clinic in the period between November 2014 and April 2016. The first group consists of glaucoma patients visiting the consultation with VPA (PVD stages 1, 2 or 3) confirmed by OCT imaging. To study the age-dependent process of PVD formation, the medical record and OCT scans of an additional group of glaucoma patients aged between 25 and 90 years old were analysed using the same criteria in order to increase statistical power comparing between healthy and glaucoma.
The second group were glaucoma patients scheduled for filtering surgery.
All Glaucoma patients in the second group received the standard pre-and postoperative treatment and follow-up augmented with an OCT scan (Heidelberg Spectralis) of the operated eye at each visit (pre-and postoperative day 1, and weeks 1, 2 and 4) to assess possible changes in disc structure and PVD status following the acute IOP lowering induced by the filtering surgery. The analysis of this subgroup is beyond the scope of this manuscript.
A history of intraocular surgery and known aberrations of the vitreous (persisting primary hyperplastic vitreous, Stickler syndrome, Ehler-Danlos, Marfan, etc.) were exclusion criteria, except for uneventful cataract surgery or glaucoma filtering surgery.
Image analysis and PVD staging
Glaucoma patients underwent Spectralis OCT following the preprogrammed GMPE scan sequence of first a Bruchs membrane opening (BMO) centred scan process of 24 radial scans over the disc followed by three circular scans around the disc margin, second a macular centred cube scan of 64 lines according to the papillomacular axis. The built-in analysis software was used to measure the Bruch's membrane opening (BMO) minimal rim width, RNFL thickness and macular thickness. A standard HRT III scan was performed in those presenting with stage 1, 2 or 3 PVD (vide infra), in addition to the OCT. The images were analysed using the HRT version 3.0 software (Heidelberg Engineering, Dossenheim, Germany). The analysis technique has been described elsewhere (Weinreb et al. 1989) . Only OCT scans with abundant quality (signal strength >15 dB) and HRT III images with a standard deviation below 40 lm were included. Recorded optic disc biometric measurements were electronically exported to the database.
All macular OCT scans were analysed according to the classification for vitreomacular interface disorders published by the VMT syndrome working group (Duker et al. 2013) . Posterior vitreous detachment (PVD) staging was done according to the classification proposed by Johnson and Sebag subdividing PVD into five stages (Sebag 1997; Johnson 2005) . Stage 0 indicates a vitreous completely attached to the retinal surface. Stage 1 is present when there is a partial vitreoretinal separation around the macular region resulting in vitreomacular adhesion (VMA). In stage 2, this VMA has resolved but the vitreopapillary attachment remains together with a vitreous attachment on the nasal side of the optic disc. Stage 3 is present when the vitreous only remains attached at the optic disc and stage 4 indicates a complete separation of the posterior vitreous cortex from the disc and the retina in the posterior pole. All images were analysed independently by two observers.
An informed consent was obtained from every prospective included subject/patient. This study was approved by the ethical review committee of the University Hospitals Leuven and was conducted in accordance with good clinical practice guidelines within the tenets of the Declaration of Helsinki.
Statistical analysis
The calculations were done using SPSS 23.0 (IBM SPSS statistics for Windows, Armonk, NY, USA). Normality was tested according to Kolmorov-Smirnov. Bonferroni correction for multiple testing was applied. Statistical significance was defined as a two-sided p-value below 0.05. Values are depicted as mean AE standard deviation (SD) or as count (percentage, %) for continuous and discrete variables respectively. According to Armstrong (2013) on the use of data of two eyes of the same subject in statistical analyses, the intraclass coefficient (ICC) was calculated for healthy (ICC = 0.92) and glaucomatous subjects (ICC = 0.87). Since the ICC approaches 1, the continuous within subject data were averaged to account for the correlation within subjects. Analyses on subject level were done using nonparametric Kruskall-Wallis and Pearson chi-squred tests, for continuous and discrete variables respectively. To investigate the possible association of glaucoma with PVD an ordinal logistic regression model was built using PVD stage as dependent variable and glaucoma (yes/no) as grouping variable while correcting for age, gender and refractive error. The results are presented as odds ratios (OR) with a 95% confidence interval (CI).
Results
Data on 523 subjects (993 eyes) were included from the VPI study database (493 eyes of 258 healthy subjects and 500 eyes of 265 glaucoma patients). Of the 500 glaucomatous eyes, 456 suffered from POAG and 44 of angle closure glaucoma (ACG). Table 1 depicts the demographic and ocular characteristics. Healthy subjects were significantly younger than POAG and ACG patients [59.7 years (AE14.81); 70.0 years (AE10.78) and 65.6 years (AE10.83), p < 0.001 respectively]. Figure 1 depicts the relative number of eyes per decade for each group. The smallest subgroup in the healthy cohort counted 28 subjects (older than 80 years) and the smallest cohort in the POAG group counted 49 eyes (younger than 51 years). There was no significant difference in gender distribution among the three groups. There were more pseudophakic glaucomatous eyes compared to their healthy counterparts (26.6% and 25.0% versus 5.1%, p < 0.001). Angle closure glaucoma (ACG) patients did have, as expected, a significantly more positive spherical equivalent (hypermetropia) and a higher IOP. A minority (7.9% and 4.5%) of POAG and ACG patients, respectively, had undergone previous filtering surgery (trabeculectomy, Xen gel stent or tube implantation) and significantly more ACG patients had glaucoma laser treatment (YAG laser iridotomy or laser trabeculoplasty) compared to POAG. Table 2 shows the number and average age for both healthy subjects and POAG patients per PVD stage (in view of the small number of ACG patients, comparing differences in age distribution lacks statistical power). For PVD stage 0, both groups were of comparable size, in contrast to stage 1, where healthy eyes outnumbered POAG with the reverse being true for PVD stage 3 and 4. For every PVD stage, healthy subjects were significantly younger than glaucoma patients. Power calculations at a significance level of 0.05 showed a power of at least 0.8 for every PVD stage comparing the average age between both groups, taking into account the differences in sample size. Because of the large significant difference in average age and proportion of pseudophakic eyes, both of which are known to be related to PVD formation, the same analysis was repeated for all phakic healthy and primary glaucomatous eyes from subjects between 50 and 80 years old. This selection reduced the age difference between healthy and glaucoma (64.1 AE 8.0 versus 65.9 AE 6.7, respectively, p = 0.051) while remaining matched for refractive error (À0.68 AE 3.32 D versus À0.25 AE 1.95 D, respectively (p = 0.29) and gender (p = 0.182) distribution. The comparison of the average age for each PVD stage between these matched subgroups confirmed the previous results indicating a significantly older age for PVD stage 1 and a trend for PVD stage 3 for glaucomatous versus healthy eyes (Fig. 2) .
Ordinal logistic regression revealed an OR of 0.60 (CI: 0.42-0.86; p = 0.005) indicating that glaucoma patients are significantly more likely to have a lower PVD stage in respect to the matched healthy subjects.
Defining the phakic, nonoperated eye with the highest PVD stage as an index eye, Table 3 depicts the PVD stage of the contralateral (phakic) eye. In the majority of the healthy subjects (83%) and POAG patients (67%), both eyes were in the same PVD stage at the time of inclusion. Only in PVD stage 3 and stage 4 for the index eye, there were more contralateral eyes in stage 0, 1 or 3 in the glaucoma group.
Discussion
The VPI study is a large trial investigating the VPI. To our best knowledge, this is the largest study investigating the frequency and staging of PVD formation in glaucoma patients. The goal of this trial was to assess the possible effect of the changing interplay between the posterior vitreous cortex and the optic disc. This seems particularly important in glaucoma, not only because of the possible tractional effects in terms of pathophysiology, but also because this changing traction can act as a significant artefact in imaging-assisted disease diagnosis and progression (Schuman et al. 2003; Weinreb et al. 2014) . Despite the combined pathophysiology of mechanical IOP-related damage and vascular alterations (blood flow/oxygenation), the treatment only focuses on reducing the intraocular pressure (Halpern & Grosskreutz 2002) . Although low-tension glaucoma patients have IOPs in the normal range, they do show signs of progressing disease. Therefore, it remains important to investigate possible additional pathologic mechanisms damaging the optic nerve head and causing visual field defects. Preferably these would render additional treatment options. Some did investigate the natural course of PVD formation and the consequent possible tractional forces on the optic disc, but in the field of glaucoma there are no large studies investigating the influence of the posterior hyaloid on the disc (Kim et al. 2014) .
This paper described the methodology of data collection within the VPI study and reports on age-related PVD formation in healthy and glaucoma. Our findings on healthy subjects compare well with previously published results, especially taking into account the differences in average age, spherical equivalent and race with respect to the publications of Uchino et al. (2001) and Itakura & Kishi (2013) . Besides these differences in the study population and ocular characteristics, also advances in the imaging of the vitreoretinal interface could play a significant role in PVD stage assessment. Optical coherence tomography (OCT) images displaying a clearly recognizable posterior vitreous cortex are straightforward to grade, but the difference between a stage 0 and a stage 4 PVD is sometimes more subtle. In our study, the presence of a posterior precortical vitreous pocket (otherwise known as premacular bursa), Cloquet's canal or Martegiani's space were regarded as signs [in the absence of a local posterior hyaloid detachment of the internal limiting membrane (ILM)] of a stage 0 PVD (Fig. 3) . The absence of these signs indicates a stage 4 PVD, which can be confirmed by a visible Weiss ring on fundoscopy or a mobile posterior vitreous cortex on dynamic ultrasound B scan. Furthermore, a stage 2 PVD was never seen in our study subjects as there was always, although sometimes minimal, separation present of the posterior hyaloid and ILM nasal to the optic disc when there was a concomitant perimacular PVD. In contrast to the recent published findings of Schwab et al. (2017) who reported glaucoma patients to experience PVD at younger age compared to healthy controls, our results indicate the opposite. However, there seem to be significant differences in the methodology of PVD stage grading as Schwab et al. discriminated between 'initial PVD' which is to be regarded as a PVD stage 1 and 'advanced PVD' which could be PVD stage 2, 3 or 4. Besides, they Fig. 1 . Distribution of the relative number of eyes for each group according to the age. The number of included eyes for every age group is depicted both for healthy and glaucoma. Ma et al. 2014 ). We acknowledge, however, that the difference in the findings between this study and previous works may relate to the use of different devices and methodologies. Furthermore, as their sample size of 48 glaucomatous eyes is fairly small and the median age of the included subjects fairly old (67 and 77 years for glaucoma and healthy, respectively), the results could be biased by the included sample. As previously reported by others, the dynamic process of PVD usually starts at around 50 years and could take up to two to three decades to complete. Therefore, it is important to have a representative sample with a large number of eyes covering these years of changing vitreoretinal interaction. We have chosen to include both eyes of the included subjects for analysis while correcting for the correlation bias within subjects by averaging the continuous data, according the Armstrong (2013) . This way the number of eyes per PVD stage for the phakic nonoperated subgroups was at least 23. More importantly, however, for a PVD stage 1, we could compare 163 healthy with 112 glaucomatous eyes, and for a PVD stage 3, 34 healthy and 48 glaucomatous eyes. When performing the same analysis for only 1, randomly selected, eye per subject, the results remained the same but with a reduction in statistical power (Table A1) . When repeating for the contralateral eye, the same trends were observed (Table A2) .
Interestingly, primary open-angle glaucoma patients appear to experience PVD at older age than their healthy counterparts, but reach full PVD (stage 4) at similar age. This is reflected by the OR indicating a significant likelihood for glaucomatous eyes to have a lower PVD stage in respect to their age, refractive error and gender matched healthy counterparts. These findings, however, do not indicate that glaucoma patients develop a PVD at later age, but the age differences in PVD stages 1 and 3 (between healthy and glaucoma) together with a similar age for PVD stage 0, do suggest that at least a subset of glaucoma patients might experience VPA (or traction) for a longer period of time in respect to healthy subjects. This is also illustrated in Fig. 4 that depicts the difference in PVD stage distribution of phakic subjects between 50 and 80 years old. The largest differences are found during the sixth decade where the majority of healthy eyes is in PVD stage 1, whereas a significant proportion (29% versus 12%) of glaucomatous eyes is in PVD stage 0. Furthermore, for the eighth decade, a large proportion (32%) of glaucomatous eyes is in PVD stage 3 while only 16% of healthy eyes are in the same PVD stage.
Although others have hypothesized that the oxidative stress in glaucomatous eyes could lead to early vitreous liquefaction and PVD, our findings suggest the opposite (Le Goff & Bishop 2008; Schwab et al. 2017) . As reactive oxygen species do disrupt hyaluronic acid (Ueno 1995) , this would have significant impact on the core vitreous, but the vitreoretinal interface consists of laminin, fibronectin and collagen and these molecules anchor the posterior vitreous cortex to the surface of the retina and optic disc (Bu et al. 2015) . Furthermore, a strong vitreoretinal adhesion is frequently observed in diabetic eyes and is associated with age-related macular degeneration (Weber-Krause & Eckardt 1996; Jackson et al. 2013). Bertelmann et al. (2016) reported that there seems to be no association between retinal ischaemia and posterior vitreous adhesion in retinal vein occlusion patients, but their study did show that the majority of the included patients had an attached posterior vitreous cortex (92% of the central retinal vein occlusion and 96% of branch retinal vein occlusion patients). Likewise, a vascular dysregulation is present in glaucoma and could influence the vitreoretinal interface significantly (Abegão Pinto et al. 2016) . Interestingly, as the vitreous body could possibly be regarded as modifiable risk factor for retinal disease associated with oxidative stress, the effect of vitrectomy on retinal oxygenation and functioning should be investigated in glaucomatous subjects. Removing the vitreous does change significantly the oxygen distribution and molecule diffusion within the eye (Stef ansson 2009) leading to increased oxygen saturation in the retinal circulation ( S ın et al. 2014 ). Next to increase in oxygen levels, vitrectomy would also remove possible vitreous traction to the RNFL in glaucoma patients. Whether glaucomatous subjects have a stronger vitreoretinal adhesion remains purely speculative, but our findings do suggest that their optic disc remains exposed to possible vitreous traction longer than healthy subjects.
Correction for possible confounding factors (refractive error, pseudophakia and gender) is mandatory when investigating the process of PVD formation. As indicated in Table 1 , there is no statistical significant difference between the healthy and POAG cohort with respect to gender distribution or refractive error. There is, however, in line with the average significant age difference between healthy and glaucoma, a significantly larger proportion of pseudophakic subjects among POAG patients. Since a large study of Ripandelli et al. (2007) showed that 78.7% of emmetropic eyes undergoing cataract surgery develop a PVD (assessed by fundoscopy and ultrasound B scan) within 26 months, pseudophakia could have a significant effect on PVD status. These results were confirmed by others using the same methodology of PVD assessment, but are in contrast to the reported 30% of funduscopic assessed PVD formation in a time period until 3 years after uneventful cataract surgery by Hikichi Hikichi 2012) . However, all of the aforementioned studies assessed PVD with the use of fundoscopy and/ or ultrasound B scan. Optical coherence tomography (OCT) imaging does allow a more specific classification and staging of PVD formation. Following cataract surgery, a more detailed analysis of progressive PVD can be done using OCT (Ivastinovic et al. 2012) . The high number (121) of older pseudophakic patients in our glaucoma cohort thus explains the difference in age for stage 4 PVD when all eyes are compared. As stage 4 is the final stage of PVD formation, a sampling error is likely to occur when both groups are not age-matched. This, however, does not apply to the progressive nature of PVD itself, indicating that our results regarding the differences in stages 1 and 3 do present an actual difference between healthy subjects and POAG patients. Nevertheless, there could be a similar sampling error regarding stage 0, thus limiting the findings of this study largely to the dynamic part of PVD, stage 1 until stage 3. This is illustrated by comparing the results of the complete group analysis versus the selection of nonoperated phakic eyes between 50 and 80 years old (Table 2 and Fig. 2, respectively) . The statistical significant difference in the average age for a PVD stage 1 is confirmed, and a trend towards significant older glaucomatous eyes is observed for a PVD stage 3. Interestingly, the PVD formation process seems to relate to individual characteristics as inter-ocular differences in PVD staging are small in both glaucoma and healthy individuals. The majority of study subjects show the same PVD stage in both eyes, except for PVD stages 3 and 4 in the glaucoma group where more contralateral eyes have a PVD stage 0, 1 or 3 (Table 3 ). This is illustrated by the overlapping time period between stage 3 and 4 both for healthy subjects and glaucoma patients. As mentioned, from a biomechanical point of view, a PVD stage 3 would be expected to exert more stress on the optic nerve head, as the tractional forces of the entire posterior hyaloid are focused on the optic disc rim, in contrast to a PVD stage 1, where the concomitant VMA would decrease the forces on the temporal side.
The major limitation of this study is the age difference between healthy and glaucomatous individuals. Performing the analysis by calculating the age of the different groups according to their PVD stage (instead of the other way around), the data do allow to investigate the difference in age distribution during PVD formation, but conclusions can only be made regarding the dynamic part of PVD formation, i.e. stages 1-3. The outcome of the ordinal logistic regression analysis supports these findings as glaucoma patients seem to have significant less chance of being in the same or higher PVD stage in respect to their healthy age-matched counterparts. Eliminating the confounding factor of previous cataract surgery and unifying both groups regarding average age, refractive error and gender distribution, the results for PVD stages 1 and 3 largely remained the same. A second limitation is the fact that this is a cross-sectional data analysis and not a long-term follow-up of healthy subjects and glaucoma patients allowing to investigate PVD formation within subjects. Especially within glaucoma patients this would be of interest, together with a progression analysis of the RNFL thinning. A third major limitation consists of the fact that no axial length measurements were done and that refractive error was used to exclude high hyperopic and myopic eyes. One of the major strengths of the study is the PVD grading using state of the art SD-OCT imaging devices. Both devices have comparable high-resolution imaging that render B-scans of similar quality suitable for straightforward PVD staging (Leite et al. 2011) .
The group of angle closure patients was not included in most of the presented analysis because of the relatively small number of patients, but this part of the data set will be important for future analyses, comparing between different glaucoma types with a different pathophysiological mechanism. Future VPI study database related research will investigate the effect of VPA on HRT and OCT optic disc biometric measurements, the possible association with visual field defects and the association with optic disc haemorrhages. Especially the impact of VPA on optic disc morphology could be of great importance in the assessment and follow-up of glaucoma patients as automated rim thickness measurements could possibly be altered by VPA and lead to so called 'green disease' (Sayed et al. 2017 ).
Conclusion
The VPI study is a large clinical trial investigating the VPI in healthy and glaucoma. Glaucoma patients experience stages 1-3 of PVD formation at older age in respect to healthy subjects, but reach complete PVD (stage 4) at similar age. Further research concerning the VPI is needed to investigate the possible role of the vitreous in the pathophysiology of glaucoma. 
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